Auflistung nach Autor "Rajendran, Vinothkumar"
Anzeige der Dokumente 1-4 von 4
-
Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
Rajendran, Ranjithkumar; Böttiger, Gregor; Dentzien, Niklas; Rajendran, Vinothkumar; Sharifi, Bischand; Ergün, Süleyman; Stadelmann, Christine; Karnati, Srikanth; Berghoff, Martin (2021) -
Efficacy of Fibroblast Growth Factor Receptor (FGFR) inhibitor Infigratinib on Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of Multiple sclerosis (MS)
Rajendran, Vinothkumar (2021)Multiple sclerosis (MS) is associated with oligodendrocytes damage resulting in demyelination, failure of remyelination and functional loss of neurons. Present therapeutic disease modifying drugs for MS are acting predominantly ... -
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55-induced EAE through ERK and Akt signalling
Kamali, Salar; Rajendran, Ranjithkumar; Stadelmann, Christine; Karnati, Srikanth; Rajendran, Vinothkumar; Giraldo-Velasquez, Mario; Berghoff, Martin (2021) -
The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis
Rajendran, Ranjithkumar; Rajendran, Vinothkumar; Böttiger, Gregor; Stadelmann, Christine; Shirvanchi, Kian; von Au, Laureen; Bhushan, Sudhanshu; Wallendszus, Natascha; Schunin, Darja; Westbrock, Victor; Liebisch, Gerhard; Ergün, Süleyman; Karnati, Srikanth; Berghoff, Martin (2023)Background and Purpose: Fibroblast growth factors and receptors (FGFR) have been shown to modulate inflammation and neurodegeneration in multiple sclerosis (MS). The selective FGFR inhibitor infigratinib has been shown to ...